- Home
- ATNM vs CCLD Comparison
ATNM vs CCLD Comparison
Compare ATNM & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- CCLD
- Stock Information
- Founded
- ATNM 2000
- CCLD 1999
- Country
- ATNM United States
- CCLD United States
- Employees
- ATNM N/A
- CCLD N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- CCLD Computer Software: Prepackaged Software
- Sector
- ATNM Health Care
- CCLD Technology
- Exchange
- ATNM Nasdaq
- CCLD Nasdaq
- Market Cap
- ATNM 56.5M
- CCLD 66.3M
- IPO Year
- ATNM N/A
- CCLD 2014
- Fundamental
- Price
- ATNM $1.17
- CCLD $3.57
- Analyst Decision
- ATNM Strong Buy
- CCLD Strong Buy
- Analyst Count
- ATNM 4
- CCLD 2
- Target Price
- ATNM $8.75
- CCLD $3.75
- AVG Volume (30 Days)
- ATNM 167.7K
- CCLD 116.0K
- Earning Date
- ATNM 03-28-2025
- CCLD 03-20-2025
- Dividend Yield
- ATNM N/A
- CCLD N/A
- EPS Growth
- ATNM N/A
- CCLD N/A
- EPS
- ATNM N/A
- CCLD N/A
- Revenue
- ATNM $81,000.00
- CCLD $111,014,000.00
- Revenue This Year
- ATNM $138.42
- CCLD N/A
- Revenue Next Year
- ATNM $16,957.05
- CCLD $1.47
- P/E Ratio
- ATNM N/A
- CCLD N/A
- Revenue Growth
- ATNM N/A
- CCLD N/A
- 52 Week Low
- ATNM $1.07
- CCLD $1.01
- 52 Week High
- ATNM $10.24
- CCLD $4.84
- Technical
- Relative Strength Index (RSI)
- ATNM 46.97
- CCLD 45.17
- Support Level
- ATNM $1.15
- CCLD $3.90
- Resistance Level
- ATNM $1.29
- CCLD $4.75
- Average True Range (ATR)
- ATNM 0.07
- CCLD 0.33
- MACD
- ATNM 0.01
- CCLD -0.06
- Stochastic Oscillator
- ATNM 46.51
- CCLD 17.48
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.